Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer

Published:2022-10 Issue: Volume:65 Page:98-103
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Ikejiri Haruka^ORCID,Sasada Shinsuke,Emi Akiko,Masumoto Norio,Kadoya Takayuki,Okada Morihito

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference26 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007;Goldhirsch;Ann Oncol,2007

3. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer;Sparano;N Engl J Med,2018

4. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age;Piccart;Lancet Oncol,2021

5. 18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis;Hong;Surg Oncol,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Narrow interval dual phase 18F-FDG PET/CT: A practical approach for distinguishing tumor recurrence from radiation necrosis in brain metastasis;Medicine;2024-05-03

2. The effect of telephone and short-message follow-ups on compliance and efficacy in asthmatic children treated with inhaled corticosteroid: A randomized controlled trial;Medicine;2024-05-03

3. Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET;Seminars in Nuclear Medicine;2024-05

4. ⁶⁸Ga labeled EphA2-targeted cyclic peptide: a novel positron imaging tracer for triple-negative breast cancer?;Dalton Transactions;2024

5. Diagnostic Superiority of Dual-Time Point [18F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors;Diagnostics;2023-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3